{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:20:55Z","timestamp":1782944455441,"version":"3.54.5"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215289","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T17:30:36Z","timestamp":1555349436000},"page":"e0215289","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antidepressants and the risk of death in older patients with depression: A population-based cohort study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-954X","authenticated-orcid":true,"given":"Bianca","family":"Kollhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Jobski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Krappweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-1866","authenticated-orcid":true,"given":"Tania","family":"Schink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Schmedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/gerona\/58.3.M249","article-title":"Depression in late life: review and commentary","volume":"58","author":"DG Blazer","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref2","unstructured":"DGPPN B, KBV, AWMF (Hrsg.) f\u00fcr die Leitliniengruppe Unipolare Depression*. S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression\u2013Langfassung, 2. Auflage 2015 [22 Aug 2018]. Version 5:[Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.leitlinien.de\/mdb\/downloads\/nvl\/depression\/depression-2aufl-vers5-lang.pdf\" xlink:type=\"simple\">https:\/\/www.leitlinien.de\/mdb\/downloads\/nvl\/depression\/depression-2aufl-vers5-lang.pdf<\/ext-link>."},{"key":"ref3","unstructured":"National Institute for Health and Clinical Excellence: NICE; 2009 [14 Jun 2016]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nice.org.uk\/guidance\/cg90\/resources\/depression-in-adults-recognition-and-management-975742636741\" xlink:type=\"simple\">https:\/\/www.nice.org.uk\/guidance\/cg90\/resources\/depression-in-adults-recognition-and-management-975742636741<\/ext-link>."},{"key":"ref4","unstructured":"American Psychiatric Association (APA). Practice Guidelines for the Treatment of Major Depressive Disorder: APA; [16 Sept 2016]. 3rd:[Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf\" xlink:type=\"simple\">http:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf<\/ext-link>."},{"issue":"17","key":"ref5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999\u20132012","volume":"314","author":"ED Kantor","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"D O'Mahony","year":"2015","journal-title":"Age and ageing"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMcp1402180","article-title":"Depression in the Elderly","volume":"371","author":"WD Taylor","year":"2014","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"C Coupland","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.1367","article-title":"Trends in psychotropic medication use among U.S. adults","volume":"16","author":"R Paulose-Ram","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00228-013-1636-z","article-title":"Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study","volume":"70","author":"J Sultana","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5414\/CP203157","article-title":"Prevalence and predictors of tricyclic antidepressant use among elderly Koreans in primary-care and specialty clinics","volume":"56","author":"JE Hwang","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/pds.1545","article-title":"Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations","volume":"17","author":"I Pigeot","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jclinepi.2009.07.001","article-title":"Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length","volume":"63","author":"H Gardarsdottir","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-016-2145-7","article-title":"Characteristics and drug use patterns of older antidepressant initiators in Germany","volume":"73","author":"K Jobski","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"ref16","article-title":"Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry","author":"C Ohlmeier","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1943-7","article-title":"Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study","volume":"15","author":"C Ohlmeier","year":"2015","journal-title":"BMC Public Health"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"H Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/oxfordjournals.aje.a009523","article-title":"Confidence limits made easy: interval estimation using a substitution method","volume":"147","author":"LE Daly","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"PM Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aet208","article-title":"Neuropathic pain in cancer","volume":"111","author":"MT Fallon","year":"2013","journal-title":"Br J Anaesth"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"S Schneeweiss","year":"2009","journal-title":"Epidemiology."},{"key":"ref23","article-title":"Performance of the high-dimensional propensity score in adjusting for unmeasured confounders","author":"JR Guertin","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1017\/S104161021600048X","article-title":"Antidepressant use and mortality in very old people","volume":"28","author":"G Bostrom","year":"2016","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/acps.12630","article-title":"Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry","volume":"134","author":"D Enache","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-10541-8","article-title":"Pharmakotherapie","author":"B Lemmer","year":"2010"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/JCP.0000000000000338","article-title":"Off-Label Prescriptions of Low-Dose Quetiapine and Mirtazapine for Insomnia in The Netherlands","volume":"35","author":"J Kamphuis","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"A Sultan","year":"2008","journal-title":"BMC Neurol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0215289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:44:02Z","timestamp":1663289042000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215289"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215289","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}